Skip to content
Home/Companies/Biotech/mo:re
mo:re

mo:re

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns mo:re?

mo:re is currently owned by High-Tech Gruenderfonds (HTGF) through HTGF IV (2022 vintage), since 2025.

Hand-verified · updated 2026-08-11

High-Tech Gruenderfonds (HTGF)
Investor
High-Tech Gruenderfonds (HTGF)
HTGF IV · 2022 · VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websitemore.science

More from HTGF IV

Other portfolio companies in the same fund.

Clee Medical
Clee Medical
Active
MedTechSwitzerland· 2026
kausable
Active
AI/MLGermany· 2026
Mycoverse
Active
AgTechDenmark· 2026
Noxon
Active
MedTechGermany· 2026
nuuEnergy
nuuEnergy
Active
ClimateTechGermany· 2026
Pixel-Flo
Active
Deep TechUnited Kingdom· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track mo:re

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on mo:re.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue